|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TRANSLATIONAL AND CLINICAL RESEARCH |
aCentre for Respiratory Research, Rayne Institute, University College London, London, United Kingdom;
bHematopoietic Stem Cell Laboratory and
cExperimental Pathology Laboratory, London Research Institute, Cancer Research UK, London, United Kingdom;
dDepartment of Histopathology and
eInstitute of Reproductive and Developmental Biology, Department of Paediatrics, Imperial College London, Hammersmith Campus, London, United Kingdom
Key Words. Tumor • Mesenchymal stem cell • Lung • Cell therapy • Osteosarcoma
Correspondence: Dominique Bonnet, Ph.D., Hematopoietic Stem Cell Laboratory, London Research Institute, Cancer Research UK, 44 Lincoln's Inn Fields, London WC2A 3PX, U.K. Telephone: 44-207-269-3282; Fax: 44-207-269-3581; e-mail: Dominique.bonnet{at}cancer.org.uk
Received on November 30, 2006;
accepted for publication on March 7, 2007.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLS EXPRESS March 15, 2007.
Murine mesenchymal stem cells are capable of differentiation into multiple cell types both in vitro and in vivo and may be good candidates to use as cell therapy for diseased or damaged organs. We have previously reported a method of enriching a population of murine MSCs that demonstrated a diverse differentiation potential both in vitro and in vivo. In this study, we show that this enriched population of murine mesenchymal stem cells embolize within lung capillaries following systemic injection and then rapidly expand within, and invade into, the lung parenchyma, forming tumor nodules. These lesions rarely contain cells bearing the immunohistochemical characteristics of lung epithelium, but they do show the characteristics of immature bone and cartilage that resembles exuberant fracture callus or well-differentiated osteosarcoma. Our findings indicate that murine mesenchymal stem cells can behave in a manner similar to tumor cells, with dysregulated growth and aberrant differentiation within the alveolar microenvironment after four passages. We demonstrate that unlike human MSCs, MSCs from different mouse strains can acquire chromosomal abnormalities after only a few in vitro passages. Moreover, other parameters, such as mouse strain used, might also play a role in the induction of these tumors. These findings might be clinically relevant for future stem cell therapy studies.
This article has been cited by other articles:
![]() |
Y. Moodley, D. Atienza, U. Manuelpillai, C. S. Samuel, J. Tchongue, S. Ilancheran, R. Boyd, and A. Trounson Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury Am. J. Pathol., July 1, 2009; 175(1): 303 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Loebinger, A. Eddaoudi, D. Davies, and S. M. Janes Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer Cancer Res., May 15, 2009; 69(10): 4134 - 4142. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ando, R. Abe, M. Sasaki, J. Murata, D. Inokuma, and H. Shimizu Bone Marrow-Derived Cells Are Not the Origin of the Cancer Stem Cells in Ultraviolet-Induced Skin Cancer Am. J. Pathol., February 1, 2009; 174(2): 595 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Walker, S. K. Shah, M. T. Harting, and C. S. Cox Jr Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation Dis. Model. Mech., January 1, 2009; 2(1-2): 23 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tasso, A. Augello, M. Carida', F. Postiglione, M. G. Tibiletti, B. Bernasconi, S. Astigiano, F. Fais, M. Truini, R. Cancedda, et al. Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds Carcinogenesis, January 1, 2009; 30(1): 150 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Loebinger, E. K. Sage, and S. M. Janes Mesenchymal Stem Cells as Vectors for Lung Disease Proceedings of the ATS, August 15, 2008; 5(6): 711 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop Stem Cells and Cell Therapies in Lung Biology and Lung Diseases Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |